Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Bladder Urothelial Carcinoma · Metastatic Renal Pelvis and Ureter Urothelial Carcinoma · Refractory Bladder Urothelial Carcinoma · Refractory Renal Pelvis and Ureter Urothelial Carcinoma · Stage IV Bladder Cancer AJCC v7 · Stage IV Renal Pelvis and Ureter Cancer AJCC v7

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic in Rochester, Rochester, Minnesota, United States
Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
Contact: Principal Investigator (Jacob J. Orme, MD, PhD)

Study leads

Jacob J. Orme, MD, PhD
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Cancer, Metastatic · Cancer · Cancer of Pancreas

Abroad (travel likely)Recruiting

Birmingham, United States · Mobile, United States

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Advanced/Metastatic Solid Tumors · Bladder Cancer · Urothelial Carcinoma

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Irvine, United States

Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma

Bladder Cancer · Urothelial Carcinoma · Metastatic Urothelial Carcinoma

Abroad (travel likely)RecruitingPHASE1

Shenzhen, China

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

Bladder Cancer · Metastatic Bladder Cancer · Unresectable Bladder Carcinoma

Abroad (travel likely)Recruiting

Boston, United States